AzTrials
AzTrials

Premature BirthNCT05246150

NIRS Levels of Infants in Neonatal Intensive Care

An observational study of Premature Birth, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: This study was conducted to determine the effect of nursing care practices on the Near Infrared Spectroscopy (NIRS) levels of premature infants in the neonatal intensive care unit (NICU). Materials and Method: This is a cross-sectional, analytical study. Read more about this study

Who is it for?
Ages 1 day to 40 daysHealthy volunteers can take part
Conditions the study is for
Premature Birth
What is being tested?
nursing care practices
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2019to 26 Apr 2019
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 40 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: 40 premature newborns

Who may be able to join

  • Neonates younger than a gestational age of 37 weeks
  • Those monitored in an open or closed incubator

Who cannot join

  • Intubated neonates connected to a mechanical ventilator
  • Infants of a gestational age of 37 weeks or more
  • Infants under sedation
  • Infants with neurological illness (e.g., hypoxic ischemic encephalopathy, hydrocdphalus)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Eskisehir

    Eskişehir, 26000

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect Of Nursıng Practıces On The Near Infrared Spectroscopy Levels Of Premature Infants

Aim: This study was conducted to determine the effect of nursing care practices on the Near Infrared Spectroscopy (NIRS) levels of premature infants in the neonatal intensive care unit (NICU).

Materials and Method: This is a cross-sectional, analytical study. It was conducted over the period March 1 - April 26, 2019 in the Neonatal Intensive Care Unit (NICU) of Eskişehir Osmangazi University (ESOGU) Health Practices and Research Hospital. We did not calculate sample size, but included in the study, after the parents had been informed about the research, the entire universe of neonates in the NICU who matched the inclusion criteria during the period March 1 - April 26, 2019. The study was completed with 40 neonates. Data collection was performed with a "Descriptive Data Form," and a "Procedures Performed Chart." The data were evaluated with the IBM SPSS 24 package program.

Conditions
Premature Birth
Being tested
nursing care practices
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • nursing care practicesBehavioural

    To determine the effect of nursing care practices on Near Infrared Spectroscopy (NIRS) levels in premature babies

Study groups in NCT05246150
Study groupRoleWhat they receive
infants receiving nursing careNot described
Receives: Behavioral: nursing care practices

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. nursing practices

    Change of nursing practices on Near Infrared Spectroscopy levels

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2022
  2. Study start1 Mar 2019
  3. Primary completion1 Apr 2019
  4. Study completion26 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
40 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT05246150
Sponsor's protocol ID
EsksehirOU
Status last verified
Feb 2022
First submitted
27 Jan 2022
Last updated
9 Mar 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Birth, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

nursing practices (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in